Frontlight ResearchEarly access
Trial site
Shinagawa-ku
- 15running trials
- 4closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer8 trials
- Triple-negative breast cancer4 trials
- Gastric and oesophageal cancer2 trials
- Liver and biliary tract cancer2 trials
- Asthma1 trial
- Brain metastases1 trial
- Colorectal cancer1 trial
- COPD1 trial
- Endometrial cancer1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 318 trials
- Phase 21 trial
- Status
- Active, not recruiting11 trials
- Completed4 trials
- Recruiting4 trials
- Lead sponsor
- AstraZeneca19 trials
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Active, not recruiting
Active, not recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026